Acadia Healthcare Company Inc [ACHC] stock is trading at $73.38, up 3.08%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The ACHC shares have gain 4.41% over the last week, with a monthly amount drifted -4.45%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Acadia Healthcare Company Inc [NASDAQ: ACHC] stock has seen the most recent analyst activity on April 25, 2024, when Deutsche Bank upgraded its rating to a Hold but kept the price target unchanged to $70 for it. Previously, Barclays started tracking the stock with Overweight rating on March 06, 2024, and set its price target to $100. On April 21, 2023, Cantor Fitzgerald initiated with a Neutral rating and assigned a price target of $83 on the stock. Deutsche Bank downgraded its rating to a Sell and decreased its price target to $63 on April 20, 2023. Loop Capital upgraded its rating to a Buy and raised its price target to $95 on December 12, 2022. Loop Capital started tracking with a Hold rating for this stock on June 17, 2022, and assigned it a price target of $72. In a note dated September 27, 2021, SVB Leerink initiated an Outperform rating and provided a target price of $85 on this stock.
Acadia Healthcare Company Inc [ACHC] stock has fluctuated between $66.49 and $87.77 over the past year. Currently, Wall Street analysts expect the stock to reach $85.89 within the next 12 months. Acadia Healthcare Company Inc [NASDAQ: ACHC] shares were valued at $73.38 at the most recent close of the market. An investor can expect a potential return of 17.05% based on the average ACHC price forecast.
Analyzing the ACHC fundamentals
Acadia Healthcare Company Inc [NASDAQ:ACHC] reported sales of 2.93B for the trailing twelve months, which represents a growth of 10.00%. Gross Profit Margin for this corporation currently stands at 0.51% with Operating Profit Margin at 0.49%, Pretax Profit Margin comes in at -0.01%, and Net Profit Margin reading is -0.01%. To continue investigating profitability, this company’s Return on Assets is posted at -0.0, Equity is -0.01 and Total Capital is 0.32. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 71.92 points at the first support level, and at 70.46 for the second support level. However, for the 1st resistance point, the stock is sitting at 74.30, and for the 2nd resistance point, it is at 75.23.
Acadia Healthcare Company Inc [ACHC] reported earnings per share of $0.85 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $0.79/share, meaning a difference of $0.06 and a surprise factor of 7.60%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were $0.91 per share as compared to estimates of $0.89 per share, a difference of $0.02 representing a surprise of 2.20%.
Ratios To Look Out For
For context, Acadia Healthcare Company Inc’s Current Ratio is 0.67. As well, the Quick Ratio is 0.67, while the Cash Ratio is 0.11. Considering the valuation of this stock, the price to sales ratio is 2.32, the price to book ratio is 2.41.
Transactions by insiders
Recent insider trading involved Miquelon Wade D, Director, that happened on Mar 05 ’24 when 2203.0 shares were sold. Director, Gregg Vicky B completed a deal on Mar 04 ’24 to sell 2500.0 shares. Meanwhile, Director OSTEEN DEBRA K sold 35000.0 shares on Dec 13 ’23.
